J7D-83700-40833 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-21
Dose 1 — Pfizer-BioNTech
2021-06-11
Dose 2 — Pfizer-BioNTech
2021-06-12
Registered in v-safe
2021-06-12
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-06-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache, Joint pains, Fatigue or tiredness, Nausea

Adult check-in
2021-06-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-06-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-06-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-09-10
Survey response — 3 months, dose 2
MedDRA: Anxiety, Fatigue, Headache, Nausea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Extreme fatigue and nausea . Headaches and anxiety.

MedDRA releases: 2024-11 · check-in free text available
2021-09-10
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-09-15
Call 1 — Could Not Reach Participant
2021-09-20
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-21	Pfizer-BioNTech
2	2021-06-11	Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 9 — 3 months, dose 2

2021-09-10

Symptoms: Extreme fatigue and nausea . Headaches and anxiety.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anxiety	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Nausea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release